Market Overview

The global Interventional Radiology Market was valued at USD 28.10 Billion in 2024 and is projected to reach USD 47.28 Billion by 2033. The market is expected to grow at a CAGR of 5.95% during the forecast period from 2025 to 2033. Growth is driven by increasing preferences for minimally invasive procedures, advancing technological innovations such as AI and augmented reality, and expanding telemedicine services that enhance access to image-guided treatments.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Interventional Radiology Market Key Takeaways

• The global interventional radiology market size was valued at USD 28.10 Billion in 2024.
• The market is forecasted to reach USD 47.28 Billion by 2033, growing at a CAGR of 5.95% during 2025-2033.
• North America dominated the market with a 38.5% share in 2024.
• Increasing prevalence of chronic diseases like cardiovascular disorders and cancer is accelerating the demand for minimally invasive treatments.
• Technological advancements, including AI integration and augmented reality (AR), are enhancing procedural precision and efficiency.
• Favorable reimbursement policies and expanding telemedicine capabilities are encouraging patient adoption of interventional radiology.

Sample Request Link: https://www.imarcgroup.com/interventional-radiology-market/requestsample

Market Growth Factors

The global interventional radiology market is seeing significant growth, largely fueled by patients' growing preference for minimally invasive procedures like catheter-based treatments. These options tend to come with fewer complications compared to traditional open surgeries. As patients become more aware of the benefits, such as quicker recovery times and shorter hospital stays, the demand for image-guided procedures is on the rise. Moreover, the increasing prevalence of chronic illnesses, including cardiovascular diseases and cancer, is a key driver behind the adoption of these less invasive techniques. Healthcare providers are ramping up their investments in advanced interventional radiology systems to broaden treatment choices, while supportive reimbursement policies are encouraging more patients to choose non-surgical options.

Technological advancements are playing a crucial role in this market's expansion. Innovations in AI-powered imaging are enhancing diagnostic accuracy and allowing for real-time analysis during procedures. Automation in workflow management is streamlining operations, and the integration of augmented reality is improving both precision and spatial awareness during interventions. The use of hybrid imaging technologies, such as PET-CT and MRI-guided procedures, is further enhancing treatment accuracy and efficiency. Exciting developments in virtual reality and robotics-assisted systems, showcased at institutions like Children’s Hospital Los Angeles, are revolutionizing patient care by boosting accuracy and shortening hospital stays.

Additionally, the growth of telemedicine, including cloud-based picture archiving and communication systems (PACS), is making it easier to access diagnostics and interventional expertise, especially in underserved areas. Government initiatives aimed at promoting early disease detection, along with insurance coverage for interventional radiology procedures and increased investments in healthcare infrastructure across various regions, are also contributing to market growth. With an aging population that is more vulnerable to chronic diseases, the demand for these innovative solutions is only expected to rise.

Market Segmentation

Analysis by Product:

• Magnetic Resonance Imaging (MRI): Dominates the market due to superior imaging capabilities and non-invasive nature, providing high-resolution detailed images without radiation exposure. It's widely used in oncology for tumor detection and biopsy guidance and benefits from continuous technological advancements including functional MRI and AI-driven imaging.
• Ultrasound Imaging Systems
• Computed Tomography (CT) Scanners
• Angiography Systems
• Fluoroscopy Systems
• Biopsy Devices
• Others

Analysis by Procedures:

• Angiography: Holds 31.2% market share in 2024, enabling precise visualization of blood vessels for early detection of cardiovascular diseases. Digital subtraction angiography (DSA) advances imaging quality and reduces risks. Increasing prevalence of coronary artery diseases and stroke propels demand.
• Angioplasty
• Embolization
• Vertebroplasty
• Thrombolysis
• Nephrostomy Placement
• Others

Analysis by Application:

• Cardiology: Critical role in diagnosing and treating cardiovascular diseases through minimally invasive procedures like angiography, stent placement, and embolization enhanced with AI-assisted imaging.
• Urology and Nephrology: Used for renal angioplasty, embolization, and drainage, addressing conditions like kidney stones and urinary obstructions.
• Oncology: Widely applied for tumor detection, biopsy guidance, and minimally invasive treatments such as radiofrequency ablation and trans arterial chemoembolization (TACE), enhanced with AI and hybrid imaging.
• Gastroenterology: Used in bile duct stenting, gastrointestinal bleeding embolization, and liver biopsies with improved fluoroscopy and ultrasound-guided interventions.
• Others

Analysis by End Use:

• Hospitals: Lead the market with 53.2% share in 2024, equipped with advanced imaging systems and multidisciplinary teams for complex interventions. Expanding funding and collaborations facilitate adoption of interventional radiology technologies.
• Clinics
• Ambulatory Surgical Centers

Regional Insights

North America dominates the interventional radiology market with a 38.5% share in 2024. The region benefits from the presence of leading medical device companies, increasing prevalence of cardiovascular diseases and cancer, favorable reimbursement policies, and strong R&D initiatives. Technological advancements such as AI integration and hybrid imaging systems enhance procedural precision. Additionally, Philips launched the CT 5300 featuring AI-driven automation in December 2024, boosting market growth. Aging populations and expanded telemedicine services further reinforce North America’s market leadership.

Recent Developments & News

• November 2024: Philips India launched the Azurion interventional radiology system to enhance neurovascular procedures with advanced C-arm rotation and AI-powered remote monitoring.
• October 2024: The VA Boston Healthcare System opened an interventional radiology suite to improve Veteran care with minimally invasive procedures.
• June 2024: GE HealthCare and MediView XR Inc. installed the OmnifyXR interventional suite at North Star Vascular and Interventional.
• June 2024: Royal Philips performed the first implantation of the Duo Venous Stent System following FDA premarket approval, advancing vascular treatment solutions.

Key Players

• Boston Scientific Corporation
• Cook Group Incorporated
• Esaote SpA
• Fujifilm Holdings Corporation
• General Electric Company
• Hologic Inc
• Koninklijke Philips N.V.
• Medtronic plc
• Nipro Corporation
• Shimadzu Corporation
• Siemens Aktiengesellschaft
• Teleflex Incorporated

Customization Note

Request For Customization:

https://www.imarcgroup.com/request?type=report&id=5636&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302